Adverse events:urinary retention · Adults with overactive bladder (OAB)
Anticholinergics may leads to higher adverse events:urinary retention compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Adults with overactive bladder (OAB)
Anticholinergics may leads to higher withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · women with premenstrual syndrome (most met DSM‐V criteria for premenstrual dysphoric disorder (PMDD))
Drospirenone plus ethinylestradiol may leads to higher withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events – musculoskeletal · weight reduction in obesity to improve survival in women with endometrial cancer
It is very uncertain whether summary of findings table ‐ Lifestyle intervention changes adverse events – musculoskeletal compared with usual care compared to placebo (very low certainty).
1 finding from 1 review
Treatment‐related adverse events · 13 people with LOPD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment‐related adverse events · adults with LOPD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events at study endpoint · preventing mental disorders
2 findings from 1 review
Adverse events at study endpoint · preventing mental disorders
2 findings from 1 review
Adverse events at study endpoint · preventing mental disorders
2 findings from 1 review
Withdrawals due to adverse events · children with asymptomatic flat feet
It is very uncertain whether prefabricated foot orthoses changes withdrawal due to adverse events compared with shoes (very low certainty).
1 finding from 1 review
RR 0.99 [0.79, 1.23]
Studies not reported
Very low
Withdrawals due to adverse events · children with asymptomatic flat feet
Custom foot orthoses showed no clear difference in withdrawal due to adverse events compared with prefabricated foot orthoses (low certainty).
1 finding from 1 review
RR 1 [0.9, 1.12]
Studies not reported
Low
Withdrawals due to adverse events · children with juvenile idiopathic arthritis and flat feet
Custom foot orthoses showed no clear difference in withdrawal due to adverse events compared with shoes (low certainty).
1 finding from 1 review
RR 0.58 [0.11, 2.94]
Studies not reported
Low
Withdrawals due to adverse events · children with juvenile idiopathic arthritis and flat feet
Prefabricated foot orthoses showed no clear difference in withdrawal due to adverse events compared with shoes; GRADE not reported.
1 finding from 1 review
RR 0.72 [0.14, 3.61]
Studies not reported
GRADE not reported
Withdrawals due to adverse events · children with juvenile idiopathic arthritis and flat feet
Custom foot orthoses showed no clear difference in withdrawal due to adverse events compared with prefabricated foot orthoses (low certainty).
1 finding from 1 review
RR 0.8 [0.13, 4.87]
Studies not reported
Low
Withdrawals due to adverse events · children with asymptomatic flat feet
Customised foot orthoses showed no clear difference in withdrawal due to adverse events compared with shoes (low certainty).
1 finding from 1 review
RR 1.05 [0.94, 1.19]
Studies not reported
Low
Withdrawals due to adverse events · children with symptomatic flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events (42 days) · adults and children with uncomplicated P falciparum malaria
Pyronaridine‐artesunate (PY‐AS) showed no clear difference in serious adverse events (42 days) compared with mefloquine plus artesunate (MQ + AS) (low certainty).
1 finding from 1 review
Serious adverse events (42 days) · adults and children with uncomplicated P falciparum malaria
Pyronaridine‐artesunate (PY‐AS) showed no clear difference in serious adverse events (42 days) compared with artemether‐lumefantrine (AL) (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Induction of Remission in Medically Refractory Crohn's Disease
It is very uncertain whether summary of findings table ‐ Stem Cell changes withdrawal due to adverse events compared with placebo or Control (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · children with chronic constipation without a physical explanation
It is very uncertain whether probiotics and osmotic laxative changes withdrawal due to adverse events compared with osmotic laxative (very low certainty).
1 finding from 1 review